MSA
DGX icon

Marino Stram & Associates’s Quest Diagnostics DGX Stock Holding History

Marino Stram & Associates’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12
Closed -$1K – 198
2019
Q1 		$1K Buy
+12
New +$1.04K ﹤0.01% 579

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Marino Stram & Associates's DGX Position: Q2 2019 in Review

Marino Stram & Associates sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 12 shares — an estimated $1K sold.

Marino Stram & Associates first reported a position in DGX in Q1 2019 and held it in 1 quarter. The position peaked at $1K in Q1 2019. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.

  • Marino Stram & Associates reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 12 Quest Diagnostics shares in Q2 2019, an estimated $1K.
  • Marino Stram & Associates first reported a position in Quest Diagnostics in Q1 2019 and held it in 1 quarter.
  • Marino Stram & Associates's Quest Diagnostics position peaked at $1K in Q1 2019.
  • 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.